前收市價 | 0.1000 |
開市 | 0.1000 |
買盤 | 0.0000 |
賣出價 | 0.1000 |
拍板 | 5.00 |
到期日 | 2024-06-21 |
今日波幅 | 0.1000 - 0.1000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 3.28k |
Ultragenyx (RARE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript May 2, 2024 Arbutus Biopharma Corporation misses on earnings expectations. Reported EPS is $-0.10178 EPS, expectations were $-0.1. Arbutus Biopharma Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
Arbutus (ABUS) delivered earnings and revenue surprises of 0% and 28.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?